Sodium thiosulfate attenuates acute lung injury in Mice

Anesthesiology

Volumn 121, Issue 6, 2014, Pages 1248-1257

  Sakaguchi, Masahiro ^a   Marutani, Eizo ^a   Shin, Hae Sook ^a   Chen, Wei ^b   Hanaoka, Kenjiro ^c   Xian, Ming ^b   Ichinose, Fumito ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; HYDROGEN SULFIDE; I KAPPA B; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; SODIUM THIOSULFATE; SULFIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; ANTIOXIDANT; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THIOSULFATE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CECAL LIGATION; CELL MEMBRANE PERMEABILITY; CYTOKINE PRODUCTION; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIGATION; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UBIQUITINATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CECUM; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; LUNG; METABOLISM; PATHOLOGY;

ACUTE LUNG INJURY; ANIMALS; ANTIOXIDANTS; CECUM; CELLS, CULTURED; CYTOKINES; HUMANS; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; THIOSULFATES;

EID: 84914145493     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000456     Document Type: Article

References (37)

1. Bernard GR: Acute respiratory distress syndrome: A historical perspective. Am J Respir Crit Care Med 2005; 172:798-806
2. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD: Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:1685-93
3. Matute-Bello G, Frevert CW, Martin TR: Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008; 295:L379-99
4. Reddy AT, Lakshmi SP, Kleinhenz JM, Sutliff RL, Hart CM, Reddy RC: Endothelial cell peroxisome proliferator-Activated receptor γ reduces endotoxemic pulmonary inflammation and injury. J Immunol 2012; 189:5411-20
5. Menden H, Tate E, Hogg N, Sampath V: LPS-mediated endothelial activation in pulmonary endothelial cells: Role of Nox2-dependent IKK-β phosphorylation. Am J Physiol Lung Cell Mol Physiol 2013; 304:L445-55
6. Koh H, Tasaka S, Hasegawa N, Yamada W, Shimizu M, Nakamura M, Yonemaru M, Ikeda E, Adachi Y, Fujishima S, Yamaguchi K, Ishizaka A: Protective role of vascular endothelial growth factor in endotoxin-induced acute lung injury in mice. Respir Res 2007; 8:60
7. Olson KR: The therapeutic potential of hydrogen sulfide: Separating hype from hope. Am J Physiol Regul Integr Comp Physiol 2011; 301:R297-312
8. Toohey JI: Sulfur signaling: Is the agent sulfide or sulfane? Anal Biochem 2011; 413:1-7
9. Szabó C: Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007; 6:917-35
10. Kimura H, Shibuya N, Kimura Y: Hydrogen sulfide is a signaling molecule and a cytoprotectant. Antioxid Redox Signal 2012; 17:45-57
11. Tokuda K, Kida K, Marutani E, Crimi E, Bougaki M, Khatri A, Kimura H, Ichinose F: Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice. Antioxid Redox Signal 2012; 17:11-21
12. Shirozu K, Tokuda K, Marutani E, Lefer D, Wang R, Ichinose F: Cystathionine ?-lyase deficiency protects mice from galactosamine/ lipopolysaccharide-induced acute liver failure. Antioxid Redox Signal 2014; 20:204-16
13. Pettersen JC, Cohen SD: Antagonism of cyanide poisoning by chlorpromazine and sodium thiosulfate. Toxicol Appl Pharmacol 1985; 81:265-73
14. Cicone JS, Petronis JB, Embert CD, Spector DA: Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 2004; 43:1104-8
15. Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FJ, Farese S: Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int 2008; 74:1444-53
16. Adirekkiat S, Sumethkul V, Ingsathit A, Domrongkitchaiporn S, Phakdeekitcharoen B, Kantachuvesiri S, Kitiyakara C, Klyprayong P, Disthabanchong S: Sodium thiosulfate delays the progression of coronary artery calcification in haemodialysis patients. Nephrol Dial Transplant 2010; 25:1923-9
17. Neuwelt EA, Brummett RE, Doolittle ND, Muldoon LL, Kroll RA, Pagel MA, Dojan R, Church V, Remsen LG, Bubalo JS: First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate. J Pharmacol Exp Ther 1998; 286:77-84
18. Faller S, Zimmermann KK, Strosing KM, Engelstaedter H, Buerkle H, Schmidt R, Spassov SG, Hoetzel A: Inhaled hydrogen sulfide protects against lipopolysaccharide-induced acute lung injury in mice. Med Gas Res 2012; 2:26
19. Francis RC, Vaporidi K, Bloch KD, Ichinose F, Zapol WM: Protective and detrimental effects of sodium sulfide and hydrogen sulfide in murine ventilator-induced lung injury. Anesthesi ology 2011; 115:1012-21
20. Suzuki K, Olah G, Modis K, Coletta C, Kulp G, Gerö D, Szoleczky P, Chang T, Zhou Z, Wu L, Wang R, Papapetropoulos A, Szabo C: Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci U S A 2011; 108:13829-34
21. Kondo K, Bhushan S, King AL, Prabhu SD, Hamid T, Koenig S, Murohara T, Predmore BL, Gojon G Sr, Gojon G Jr, Wang R, Karusula N, Nicholson CK, Calvert JW, Lefer DJ: H2S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation 2013; 127:1116-27
22. Whiteman M, Li L, Rose P, Tan CH, Parkinson DB, Moore PK: The effect of hydrogen sulfide donors on lipopolysaccharide- induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal 2010; 12:1147-54
23. Peters K, Unger RE, Brunner J, Kirkpatrick CJ: Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res 2003; 60:49-57
24. Liu S, Chen ZJ: Expanding role of ubiquitination in NF-?B signaling. Cell Res 2011; 21:6-21
25. Zhang X, Zhang J, Zhang L, van Dam H, ten Dijke P: UBE2O negatively regulates TRAF6-mediated NF-κB activation by inhibiting TRAF6 polyubiquitination. Cell Res 2013; 23:366-77
26. Shembade N, Ma A, Harhaj EW: Inhibition of NF-?B signaling by A20 through disruption of ubiquitin enzyme complexes. Science 2010; 327:1135-9
27. Zou L, Feng Y, Zhang M, Li Y, Chao W: Nonhematopoietic tolllike receptor 2 contributes to neutrophil and cardiac function impairment during polymicrobial sepsis. Shock 2011; 36:370-80
28. Ichinose F, Zapol WM, Sapirstein A, Ullrich R, Tager AM, Coggins K, Jones R, Bloch KD: Attenuation of hypoxic pulmonary vasoconstriction by endotoxemia requires 5-lipoxygenase in mice. Circ Res 2001; 88:832-8
29. Sasakura K, Hanaoka K, Shibuya N, Mikami Y, Kimura Y, Komatsu T, Ueno T, Terai T, Kimura H, Nagano T: Development of a highly selective fluorescence probe for hydrogen sulfide. J Am Chem Soc 2011; 133:18003-5
30. Chen W, Liu C, Peng B, Zhao Y, Pacheco A, Xian M: New fluorescent probes for sulfane sulfurs and the application in bioimaging. Chem Sci 2013; 4:2892-6
31. Markman M, Cleary S, Pfeifle CE, Howell SB: High-dose intracavitary cisplatin with intravenous thiosulfate. Low incidence of serious neurotoxicity. Cancer 1985; 56:2364-8
32. Goel R, Cleary SM, Horton C, Kirmani S, Abramson I, Kelly C, Howell SB: Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin. J Natl Cancer Inst 1989; 81:1552-60
33. Pan LL, Liu XH, Gong QH, Wu D, Zhu YZ: Hydrogen sulfide attenuated tumor necrosis factor-A-induced inflammatory signaling and dysfunction in vascular endothelial cells. PLoS One 2011; 6:e19766
34. Sen N, Paul BD, Gadalla MM, Mustafa AK, Sen T, Xu R, Kim S, Snyder SH: Hydrogen sulfide-linked sulfhydration of NF-?B mediates its antiapoptotic actions. Mol Cell 2012; 45:13-24
35. Chung JY, Park YC, Ye H, Wu H: All TRAFs are not created equal: Common and distinct molecular mechanisms of TRAFmediated signal transduction. J Cell Sci 2002; 115:679-88
36. Shibuya N, Mikami Y, Kimura Y, Nagahara N, Kimura H: Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem 2009; 146:623-6
37. Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, Kimura H: 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 2009; 11:703-14